Color-coded markers may help doctors diagnose neural diseases through the eyes

Aug 15, 2012

Sticky plaques of proteins called amyloids mark several different, though related degenerative brain diseases including Alzheimer's, Parkinson's and Creutzfeld-Jacobs. The symptoms of these disorders overlap and methods to diagnose and monitor them are not very advanced.

To solve this problem, scientists at the University of California, San Diego, have devised several new fluorescent probes that change color depending on what type of amyloid they encounter. Because amyloids accumulate in the eye as well as the brain, their discovery offers hope that one day neurodegenerative diseases could be differentially diagnosed with simple or ointment and an .

"The key trick here is that the small differences in the proteins that make up different forms of amyloid interact differently with our fluorescent probes to result in measurably different colors of the emitted light," said who, along with Emmanuel Theodorakis, led the project. Both are professors of chemistry and biochemistry at UC San Diego. Christina Sigurdson from the Department of Pathology at UC San Diego's School of Medicine was a key collaborator in this work.

The colors vary depending on the physical properties of pockets in the different . The team demonstrated that one of their probes glows yellow when marking amyloid deposits associated with prion disease, and green when it binds to amyloids associated with Alzheimer's disease in tissue samples, for example. Their findings are published online this week by the .

Among the few available diagnostics for Alzheimer's disease are radioactive molecules that target amyloid, which can be detected in the brain using positron or . But that test only says whether amyloid has formed in the brain without distinguishing between the various types.

"We think that our approach represents a significant step towards developing diagnostics to distinguish between different, but closely related diseases where symptoms and pathological characteristics show may similarities," Yang said. "Such capability might prove to be very important for deciding on effective treatment strategies for specific diseases."

Now that they have learned how physical properties of amyloid control the colors of their markers, they are expanding their catalog to create probes for discriminating between other forms of amyloid.

The technology has been licensed for commercial development of diagnostic tests for human neural disease.

Explore further: Engineering a protein to prevent brain damage from toxic agents

Related Stories

Researchers find new piece in Alzheimer's puzzle

Feb 25, 2009

Yale researchers have filled in a missing gap on the molecular road map of Alzheimer's disease. In the Feb. 26 issue of the journal Nature, the Yale team reports that cellular prion proteins trigger the process by which ...

Mutant proteins result in infectious prion disease in mice

Dec 05, 2008

A worldwide group of scientists has created an infectious prion disease in a mouse model, in a step that may help unravel the mystery of this progressive disease that affects the nervous system in humans and animals. The ...

Alzheimer's prevention role discovered for prions

Jul 03, 2007

A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified. It appears that the normal prions produced by the body help to prevent the plaques that build up in the brain to cause Alzheimer’s ...

Recommended for you

Two teams pave way for advances in 2D materials

4 hours ago

This month's headlines on two-dimensional polymers showed noteworthy headway. "2-D Polymer Crystals Confirmed At Last," said Chemical & Engineering News. "Engineers Make the World's First Verified, 2-Dimensional P ...

Nature inspires a greener way to make colorful plastics

22 hours ago

Long before humans figured out how to create colors, nature had already perfected the process—think stunning, bright butterfly wings of many different hues, for example. Now scientists are tapping into ...

User comments : 0